-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q3 2019 to Q4 2024.
- Taysha Gene Therapies, Inc. General and Administrative Expense for the quarter ending December 31, 2024 was $6.63M, a 1.34% decline year-over-year.
- Taysha Gene Therapies, Inc. General and Administrative Expense for the twelve months ending December 31, 2024 was $29M, a 3.64% decline year-over-year.
- Taysha Gene Therapies, Inc. annual General and Administrative Expense for 2024 was $29M, a 3.64% decline from 2023.
- Taysha Gene Therapies, Inc. annual General and Administrative Expense for 2023 was $30M, a 19.6% decline from 2022.
- Taysha Gene Therapies, Inc. annual General and Administrative Expense for 2022 was $37.4M, a 9.59% decline from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)